Diabetes Mellitus, Type 2
"Diabetes Mellitus, Type 2" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.
MeSH Number(s)
C18.452.394.750.149
C19.246.300
Concept/Terms
Diabetes Mellitus, Type 2- Diabetes Mellitus, Type 2
- Diabetes Mellitus, Ketosis-Resistant
- Diabetes Mellitus, Ketosis Resistant
- Ketosis-Resistant Diabetes Mellitus
- Diabetes Mellitus, Maturity-Onset
- Diabetes Mellitus, Maturity Onset
- Diabetes Mellitus, Non Insulin Dependent
- Diabetes Mellitus, Non-Insulin-Dependent
- Non-Insulin-Dependent Diabetes Mellitus
- Type 2 Diabetes Mellitus
- Diabetes Mellitus, Slow-Onset
- Diabetes Mellitus, Slow Onset
- Slow-Onset Diabetes Mellitus
- Diabetes Mellitus, Stable
- Stable Diabetes Mellitus
- Diabetes Mellitus, Type II
- Maturity-Onset Diabetes Mellitus
- Maturity Onset Diabetes Mellitus
- MODY
- NIDDM
- Diabetes Mellitus, Adult-Onset
- Adult-Onset Diabetes Mellitus
- Diabetes Mellitus, Adult Onset
- Diabetes Mellitus, Noninsulin Dependent
Below are MeSH descriptors whose meaning is more general than "Diabetes Mellitus, Type 2".
Below are MeSH descriptors whose meaning is more specific than "Diabetes Mellitus, Type 2".
This graph shows the total number of publications written about "Diabetes Mellitus, Type 2" by people in Harvard Catalyst Profiles by year, and whether "Diabetes Mellitus, Type 2" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 10 | 4 | 14 |
| 1994 | 18 | 8 | 26 |
| 1995 | 22 | 8 | 30 |
| 1996 | 21 | 11 | 32 |
| 1997 | 23 | 6 | 29 |
| 1998 | 34 | 14 | 48 |
| 1999 | 34 | 11 | 45 |
| 2000 | 35 | 11 | 46 |
| 2001 | 41 | 11 | 52 |
| 2002 | 57 | 25 | 82 |
| 2003 | 81 | 27 | 108 |
| 2004 | 88 | 29 | 117 |
| 2005 | 92 | 29 | 121 |
| 2006 | 122 | 20 | 142 |
| 2007 | 147 | 36 | 183 |
| 2008 | 148 | 38 | 186 |
| 2009 | 143 | 32 | 175 |
| 2010 | 177 | 41 | 218 |
| 2011 | 180 | 49 | 229 |
| 2012 | 246 | 52 | 298 |
| 2013 | 228 | 42 | 270 |
| 2014 | 225 | 57 | 282 |
| 2015 | 233 | 36 | 269 |
| 2016 | 252 | 64 | 316 |
| 2017 | 248 | 52 | 300 |
| 2018 | 284 | 53 | 337 |
| 2019 | 326 | 47 | 373 |
| 2020 | 328 | 48 | 376 |
| 2021 | 350 | 39 | 389 |
| 2022 | 437 | 7 | 444 |
| 2023 | 329 | 1 | 330 |
Below are the most recent publications written about "Diabetes Mellitus, Type 2" by people in Profiles.
-
Prediabetes in pregnancy - follow-up, treatment, and outcomes compared to overt pregestational diabetes. J Matern Fetal Neonatal Med. 2023 Dec; 36(1):2191153.
-
Postpartum women's experiences in a randomized controlled trial of a web-based lifestyle intervention following Gestational Diabetes: a qualitative study. J Matern Fetal Neonatal Med. 2023 Dec; 36(1):2194012.
-
Efficacy of Sotagliflozin in Adults With Type 2 Diabetes in Relation to Baseline Hemoglobin A1c. J Am Coll Cardiol. 2023 Nov 07; 82(19):1842-1851.
-
Regulatory T cells shield muscle mitochondria from interferon-?-mediated damage to promote the beneficial effects of exercise. Sci Immunol. 2023 Nov 03; 8(89):eadi5377.
-
The GenoVA study: Equitable implementation of a pragmatic randomized trial of polygenic-risk scoring in primary care. Am J Hum Genet. 2023 Nov 02; 110(11):1841-1852.
-
Response to Comment on Elsayed et al. 5. Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes: Standards of Care in Diabetes-2023. Diabetes Care 2023;46(Suppl. 1):S68-S96. Diabetes Care. 2023 11 01; 46(11):e214.
-
Comparative Cardiovascular Effectiveness and Safety of SGLT-2 Inhibitors, GLP-1 Receptor Agonists, and DPP-4 Inhibitors According to Frailty in Type 2 Diabetes. Diabetes Care. 2023 11 01; 46(11):2004-2014.
-
Association of Gestational Diabetes With Subsequent Long-Term Risk of Mortality. JAMA Intern Med. 2023 Nov 01; 183(11):1204-1213.
-
Prevalence and Overlap of Cardiac, Renal, and Metabolic Conditions in US Adults, 1999-2020. JAMA Cardiol. 2023 Nov 01; 8(11):1050-1060.
-
Clonal Hematopoiesis of Indeterminate Potential (CHIP) and Incident Type 2 Diabetes Risk. Diabetes Care. 2023 11 01; 46(11):1978-1985.